Remote Monitoring of Axial Spondyloarthritis

NACompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Axial Spondyloarthritis
Interventions
OTHER

Usual care

"Conventional follow-up strategy with blood tests, patient-reported outcomes, and pre-scheduled visits at the hospital every 6th month.~Continue using medical treatment with tumour necrosis factor inhibitors (TNFi). Patients will be instructed to use NSAIDs should they experience minor worsening of symptoms, but if the patients experience significant symptom worsening and suspect a severe disease worsening (flare) or adverse events, they will be instructed contact the hospital."

OTHER

Remote monitoring

"Hospital health professionals perform remote monitoring of frequent patient-reported outcomes, blood test results, and physical activity data available on a digital platform.~Continue using medical treatment with tumour necrosis factor inhibitors (TNFi). Patients will be instructed to use NSAIDs should they experience minor worsening of symptoms, but if the patients experience significant symptom worsening and suspect a severe disease worsening (flare) or adverse events, they will be instructed contact the hospital ."

OTHER

Patient-initiated care

"No pre-scheduled visits or remote monitoring.~Continue using medical treatment with tumour necrosis factor inhibitors (TNFi). Patients will be instructed to use NSAIDs should they experience minor worsening of symptoms, but if the patients experience significant symptom worsening and suspect a severe disease worsening (flare) or adverse events, they will be instructed contact the hospital."

Trial Locations (1)

0319

Diakonhjemmet Hospital, Oslo

All Listed Sponsors
lead

Diakonhjemmet Hospital

OTHER

NCT05031767 - Remote Monitoring of Axial Spondyloarthritis | Biotech Hunter | Biotech Hunter